Fiorella Guadagni,
Chief
Fiorella Guadagni received her M.D. degree (summa cum laude) in 1983 at the University of Perugia. Specialized in Oncology (summa cum laude) at the University of Rome "Tor Vergata" in 1987 and in Clinical Pathology (summa cum laude) at the University of Rome La Sapienza in 1996. In 2002 she completed a Master in Economy and Health Management, University of Rome “Tor Vergata”, Italy; Ph.D degree in Medical Biotechnologies at the University of Rome Tor Vergata, School of Medicine, in 2009.
In 1985 she joined the Laboratory of Tumor Immunology & Biology, National Cancer Institute, N.I.H., Bethesda, MD, USA as a Fogarty fellow, and in 1988, was appointed as a visiting scientist. In 1991 she joined the Laboratory of Cellular Metabolism, Regina Elena National Cancer Institute, Rome as a senior staff researcher. From 1993 to 2000 she worked as a senior staff member, from 2000 to 2005 as Director of the Laboratory of Clinical Pathology, Regina Elena National Cancer Institute of Rome, and from 2005 to present as Director of Department of Laboratory Medicine and Advanced Biotechnologies” IRCCS San Raffaele Pisana, Rome, Italy. From 2006 she is the Coordinator of the Interinstitutional Multidisciplinary Biobank (BioBIM) at the San Raffaele Pisana Research Institute and from 2010 she was appointed as Scientific Coordinator Catania Research Center of the San Raffaele SpA. From 1997 she is also Contract Professor in "Tumor Immunology" at the Oncology School, School of Medicine, University of Rome "Tor Vergata", in “Biotechnologies in Oncology”, at the “Oncobiopathology School”, School of Medicine, University of Palermo. From 2005 she is contract professor at the Pathology School, School of Medicine, School of Medicine, University of Rome "Tor Vergata" and adjunct professor in Medical Oncology and Applied Biology at the Nursing School and Laboratory Technician School, School of Medicine, University of Rome La Sapienza and contract professor in Clinical Pathology at the Nursing School, School of Medicine, University of Tor Vergata, Rome, Italy.
Her major scientific interest is focused on translational research involving the design of new diagnostic strategies for human cancer. Firstly, developing several types of new immunoassays to better evaluate the presence of circulating tumor antigens potentially useful in monitoring human cancer. Recent research interests have broadened to include the investigation of different pro-inflammatory cytokines involved in cancer and to studying novel cancer diagnostic strategies, with emphasis being placed on the identification and development of molecular diagnostics tools. More recently, her scientific interest is dedicated to proteomics studies for the discovery of biomarkers of diagnostic potential for early diagnosis and discrimination of several neurodegenerative and cardiovascular diseases and functional genomic and proteomic approaches in cancer and neurodegenerative diseases research.
Dr Guadagni has been and is the principal investigator and/or coordinator of numerous studies granted by governmental and scientific organizations and is a member of several national and international scientific societies and of Editorial Boards and reviewer of several Peer-Reviewed Scientific Journals.
Dr. Guadagni is author of 134 papers published in international journals for a total Impact Factor of 500,9, with an Index H of 26, more than 20 chapters book and more than 300 abstracts presented at national and international meetings.
|
|
